What's happening
This bill removes the expiration date for the Empire State Stem Cell Board, allowing it to continue making grants indefinitely.
Why it matters
Ensures ongoing public investment in stem cell research. , which could accelerate medical breakthroughs and support New York’s position as a leader in biomedical innovation.
Provides stability for researchers and institutions. by removing uncertainty about future funding, making it easier for long-term planning, recruitment, and retention of top scientific talent.
Signals a long-term policy commitment to advancing regenerative medicine. and related fields, potentially attracting additional private and federal investment to New York.
Could shape statewide health priorities. by allowing the Empire State Stem Cell Board to continue setting research agendas and ethical standards without interruption.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Extend Stem Cell Board
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
1318
2025-2026 Regular Sessions
IN SENATE
January 9, 2025
Introduced by Sen. HOYLMAN-SIGAL -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law and part H of chapter 58 of the laws of 2007 amending the public health law, the public officers law and the state finance law relating to establishing the empire state stem cell board, in relation to the continuation of the empire state stem cell board
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 1 of section 265-a of the public health law, as amended by section 1 of part M of chapter 57 of the laws of 2021, is amended to read as follows:
1. The empire state stem cell board ("board"), comprised of a funding committee and an ethics committee, both of which shall be chaired by the commissioner, is hereby created within the department for the purpose of administering the empire state stem cell trust fund ("fund"), created pursuant to section ninety-nine-p of the state finance law. The board is hereby empowered, subject to annual appropriations and other funding authorized or made available, to make grants to basic, applied, translational or other research and development activities that will advance scientific discoveries in fields related to stem cell biology[; provided, however, that the board shall not make any grants on or after April first, two thousand twenty-one].
§ 2. Section 4 of part H of chapter 58 of the laws of 2007 amending the public health law, the public officers law and the state finance law relating to establishing the empire state stem cell board, as amended by section 2 of part M of chapter 57 of the laws of 2021, is amended to read as follows:
§ 4. This act shall take effect immediately and shall be deemed to have been in full force and effect on and after April 1, 2007 [and shall expire and be deemed repealed December 31, 2025].
§ 3. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00987-01-5
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law and part H of chapter 58 of the laws of 2007 amending the public health law, the public officers law and the state finance law relating to establishing the empire state stem cell board, in relation to the continuation of the empire state stem cell board
SUMMARY OF PROVISIONS::
Section 1 of the bill amends subdivision 1 of section 265-a of the Public Health Law to repeal language adopted in the FY 2021-2022 State Budget that limits the Empire State Stem Cell Board from making any grants on or after April 1, 2021.
Section 2 of the bill amends section 4 of Part H of Chapter 58 of the Laws of 2007 amending the Public Health Law, the Public Officers Law and the State Finance Law relating to establishing the Empire State Stem Cell Board to repeal language adopted in the FY 2021-2022 State Budget that end the Empire State Stem Cell Board effective December 31, 2027.
Section 3 of the bill is the effective date.
JUSTIFICATION::
Since 2007, the NYSTEM program has funded cutting-edge stem cell research and positioned New York State as a global leader in regenera- tive medicine research. Since its creation, NYSTEM has attracted more than $160 million in additional grant funding, over $250 million in venture capital investment and supported more than 750 jobs across the state.
Ending the NYSTEM program will damage the State's reputation as a leader in scientific research and cut off an important pipeline for ground- breaking research, attracting world-class scientists, and generating innovation.
This legislation would preserve the existence of NYSTEM and restore its grant-making power subject to appropriations in future State budgets.
LEGISLATIVE HISTORY::
S.554 of 2023-2024 (Hoylman-Sigal): Died in Health
A.3433 of 2023-2024 (Seawright): Died in Health
S.6623-A of 2021-2022 (Hoylman): Died in Health
A.7984 of 2021-2022 (Seawright): Died in Health
FISCAL IMPLICATIONS::
To be determined.
EFFECTIVE DATE::
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.